The effect of PD-L1 testing on the cost-effectiveness and economic impact of immune checkpoint inhibitors for the second-line treatment of NSCLC

Aguiar, P N ; Perry, L A ; Penny-Dimri, J ; Babiker, H ; Tadokoro, H ; de Mello, R A ; Lopes, G L

Annals of oncology, 2017-09, Vol.28 (9), p.2256-2263 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível